A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study

The purpose of this study was to determine the response to CPT-11 administered every three weeks to adults with progressive malignant glioma, treated with or without enzyme-inducing antiepileptic drug (EIAED) therapy, at the recommended phase 2 dose determined from a previous phase 1 study. Adult pa...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Prados, Michael D., Lamborn, Kathleen, Yung, W.K.A., Jaeckle, Kurt, Robins, H. Ian, Mehta, Minesh, Fine, Howard A., Wen, Patrick Y., Cloughesy, Timothy, Chang, Susan, Nicholas, M. Kelly, Schiff, David, Greenberg, Harry, Junck, Larry, Fink, Karen, Hess, Ken, Kuhn, John
Materialtyp: Artigo
Språk:Inglês
Publicerad: Duke University Press 2006
Ämnen:
Clinical Investigations
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1871932/
https://ncbi.nlm.nih.gov/pubmed/16533878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2005-010
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk